newsfilter
← Latest News
Business Wire·

Alzamend Neuro Announces Initial Closing of Private Placement

Investor had agreed to purchase up to $25 million of preferred shares Alzamend expects to use proceeds to further its clinical trials and working capital purposes Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"),